Navigation Links
WomanCare Global to Distribute Mifepristone in Europe and Africa
Date:2/9/2012

LONDON, Feb. 9, 2012 /PRNewswire-USNewswire/ -- WomanCare Global announced today that mifepristone has been added to their reproductive healthcare portfolio.  Through an agreement with Linepharma, WomanCare Global will provide sales, marketing, provider training and distribution of mifepristone in seven European and seven African countries. 

(Logo: http://photos.prnewswire.com/prnh/20101018/DC83896LOGO )

Linepharma's mifepristone is labeled for use as a single 200mg tablet of mifepristone to perform medical abortion in conjunction with a prostaglandin, in compliance with the World Health Organization's recommendation. Linepharma's mifepristone is manufactured in Europe and is currently approved in five E.U. countries.

The planned distribution of mifepristone by WomanCare Global in 14 countries will ensure that close to 55 million women will have another safe, quality product to manage their reproductive health.  

"To date, a European-approved mifepristone has only been available in a limited geographic area," said WomanCare Global CEO Saundra Pelletier. "Providing access to quality reproductive health supplies ensures that women can choose if and when to have children.  This is a critical factor in helping women live to their fullest potential."

"Teaming with WomanCare Global is an achievement for Linepharma which has been built with the aim to bring products approved by the most demanding regulatory agencies and to provide not-for-profit organizations with pharmaceutical support in order to allow women in developing countries to get access to high-quality medicines" said Linepharma General Manager Thomas Kozminski.

"In our many years of working in women's reproductive health, we are very aware of the unmet need for higher quality products. We are so pleased that WomanCare Global is able to provide a solution and make an EU-manufactured mifepristone available to the women we serve," said Ipas CEO Liz Maguire.  "Ipas will work very closely with WomanCare Global on expanding access to mifepristone in Africa.  Bringing this life saving technology to women in low-resource settings is critical to reducing deaths and injuries from unsafe abortion and helping women make their own reproductive decisions."

About WomanCare Global
WomanCare Global is a nonprofit organization working with partners around the world to improve the lives of women by providing access to affordable, quality reproductive health products. The organization believes that every woman, no matter where she lives, should have control over her reproductive health and family planning needs, ultimately improving her ability to care for herself and her family. WomanCare Global closes the access gap by bringing the same quality products available in the developed world to developing countries. WomanCare Global serves both public and private sectors via an established global supply chain reaching countries around the world, with particular focus on under-served markets in Africa, Asia and Latin America. WomanCare Global was established by Ipas in 2009 and the two organizations continue to work closely together.  WomanCare Global operates independently as a UK Registered Charity (No. 1138896).  For more information, please visit womancareglobal.org

About Linepharma
Linepharma is a European pharmaceutical company which identifies, develops and registers medicines or medical devices which offer health benefits to women and need specific approaches for commercialization. Currently, the company is focused to make medical abortion safe and affordable and to develop medicines for the treatment and prevention of ob/gyn conditions such as post-partum haemorrhage. Linepharma contributes to training services related to the use of its medicines in developed and developing countries.

 

 

 


'/>"/>
SOURCE WomanCare Global
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. WomanCare Global Highlights the Unmet Need of 215 Million Women on Famous CBS Super Screen in Times Square
2. WomanCare Global Acquires 2 Global Brands From ICON -- Combined Oral Contraceptive Roselle® and Emergency Contraceptive Optinor®
3. Perrigo Company to Present at the Leerink Swann 2012 Global Healthcare Conference
4. Boston Scientific to Participate in Leerink Swann 2012 Global Healthcare Conference
5. Cambrex to Present at UBS 22nd Annual Global Healthcare Services Conference
6. CORRECTION - Transparency Market Research: Global Osteoporosis Market is Expected to Attain a Market Size of USD 11.4 billion in 2015, China Osteoporosis Market Will be Worth USD 2.5 Billion in 2015
7. Generic Pharmaceuticals Market - A Global Analysis
8. Hill-Rom to Participate in the Leerink Swann 2012 Global Healthcare Conference
9. Auxilium Pharmaceuticals to Present at the Leerink Swann 2012 Global Healthcare Conference
10. MarketsandMarkets: Global In-Vitro Diagnostic (IVD) Market Expected to Reach $64 Billion by 2016
11. Kerry to Expand Center of Excellence with New Cell Science Laboratory Serving Bio-Pharma Customers Globally
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... -- The Rebound mobile app is poised to become a ... of prescription drug addiction. The app empowers users to develop ... down their dosage in a safe, controlled manner while maximizing ... first 100,000 people to sign up will enjoy 3 months ... ...
(Date:9/28/2017)... 28, 2017 Cohen Veterans Bioscience and Early ... of wearable and home sensors for real-time monitoring of ... Foundation, a nonprofit organization focused on disruptive health solutions ... affordable analytical system to record and integrate behavioral, cognitive, ... ...
(Date:9/27/2017)... YORK , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a ... today announced that its MyDario product is expected to appear on The ... when The Dr. Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz ... The ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a leading ... Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will revolutionize the rapidly ... CBD form that can be easily incorporated into liquid products, while reducing costs to ...
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance ... care insurance companies have a waiver for care if the client has a cognitive ... the family pays for care, is often waived, so the benefits from their insurance ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Yisrayl Hawkins, Pastor ... that explains one of the most popular and least understood books in the Holy ... and puzzling descriptions that have baffled scholars for centuries. Many have tossed it off ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: ... “America On The Brink” is the creation of published author, William Nowers. ... As a WWII veteran, he spent thirty years in the Navy. Following ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has ... today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula ... the highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, ...
Breaking Medicine News(10 mins):